Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.

Authors

Kristina K Hardy, George Washington UniversityFollow
Leanne Embry
John A Kairalla
Shanjun Helian
Meenakshi Devidas
Daniel Armstrong
Stephen Hunger
William L Carroll
Eric Larsen
Elizabeth A Raetz
Mignon L Loh
Wenjian Yang
Mary V Relling
Robert B Noll
Naomi Winick

Document Type

Journal Article

Publication Date

7-3-2017

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Volume

35

Issue

23

Inclusive Pages

2700-2707

DOI

10.1200/JCO.2016.71.7587

APA Citation

Hardy, K., Embry, L., Kairalla, J., Helian, S., Devidas, M., Armstrong, D., Hunger, S., Carroll, W., Larsen, E., Raetz, E., Loh, M., Yang, W., Relling, M., Noll, R., & Winick, N. (2017). Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 (23). http://dx.doi.org/10.1200/JCO.2016.71.7587

Peer Reviewed

1